Immunopathology of highly virulent pathogens: Insights from Ebola virus

Nature Immunology

Volumn 8, Issue 11, 2007, Pages 1159-1164

  Zampieri, Carisa A ^a,b   Sullivan, Nancy J ^a   Nabel, Gary J ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN; IMMUNOGLOBULIN M; NEUTRALIZING ANTIBODY; VIRUS GLYCOPROTEIN; VIRUS VACCINE;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; ARTICLE; BLOOD VESSEL PERMEABILITY; CELLULAR IMMUNITY; CYTOTOXICITY; DENDRITIC CELL; EBOLA VIRUS; HOST PATHOGEN INTERACTION; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; INNATE IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SEVERE ACUTE RESPIRATORY SYNDROME; T LYMPHOCYTE ACTIVATION; VACCINATION; VASODILATATION; VIRUS INFECTION; VIRUS REPLICATION; VIRUS VIRULENCE;

ANIMALS; BLOOD VESSELS; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; HUMANS; LIVER;

EID: 35549005397     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1519     Document Type: Article

References (67)

1. Bowen, E.T. et al. Viral haemorrhagic fever in southern Sudan and northern Zaire. Preliminary studies on the aetiological agent. Lancet 1, 571-573 (1977).
2. Johnson, K.M., Lange, J.V., Webb, P.A. & Murphy, F.A. Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire. Lancet 1, 569-571 (1977).
3. Leroy, E.M. et al. Fruit bats as reservoirs of Ebola virus. Nature 438, 575-576 (2005).
4. Zaki, S.R. & Goldsmith, C.S. Pathologic features of filovirus infections in humans. Curr. Top. Microbiol. Immunol. 235, 97-116 (1999).
5. Bwaka, M.A. et al. Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: Clinical observations in 103 patients. J. Infect. Dis. 179 (suppl. 1), S1-S7 (1999).
6. Ksiazek, T.G. et al. Clinical virology of Ebola hemorrhagic fever (EHF): Virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J. Infect. Dis. 179 (suppl. 1), S177-SI87 (1999).
7. Sanchez, A. et al. Filoviridae: Marburg and Ebola Viruses. In Fields Virology (eds. Knipe, D.M. & Howley, P.M.) 1279-1304 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
8. Geisbert, T.W. et al. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: Evidence that dendritic cells are early and sustained targets of infection. Am. J. Pathol. 163, 2347-2370 (2003).
9. Connolly, B.M. et al. Pathogenesis of experimental Ebola virus infection in guinea pigs. J. Infect. Dis. 179; S203-S217 (1999).
10. Hensley, L.E., Young, H.A., Jahrling, P.B. & Geisbert, T.W. Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily. Immunol. Lett. 80, 169-179 (2002).
11. Feldmann, H. et al. Filovirus-induced enclothelial leakage triggered by infected monocytes/macrophages. J. Virol. 70, 2208-2214 (1996).
12. Bray, M. & Geisbert, T.W. Ebola virus: The role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever. Int. J. Biochem. Cell Biol. 37, 1560-1566 (2005).
13. Mohamadzadeh, M. et al. Activation of triggering receptor expressed on myeloid cells-1 on human neutrophils by Marburg and Ebola viruses. J. Virol. 80, 7235-7244 (2006).
14. Geisbert, T.W. et al. Mechanisms underlying coagulation abnormalities in Ebola hemorrhagic fever: Overexpression of tissue factor in primate monocytes/macrophages is a key event. J. Infect. Dis. 188, 1618-1629 (2003).
15. Gupta, M., Spiropoulou, C. & Rollin, P.E. Ebola virus infection of human PBMCs causes massive death of macrophages, CD4 and CD8 T cell sub-populations in vitro. Virology 364, 45-54 (2007).
16. Bosio, C.M. et al. Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation. J. Infect Dis. 188, 1630-1638 (2003).
17. Mahanty, S. et al. Cutting edge: Impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses. J. Immunol. 170 2797-2801 (2003).
18. Bosio, C.M. et al. Ebola and Marburg virus-like particles activate human myeloid dendritic cells. Virology 326, 280-287 (2004).
19. Martinez, O., Valmas, C. & Basler, C.F. Ebola virus-like particle-induced activation of NF-κB and Erk signaling in human dendritic cells requires the glycoprotein mucin domain. Virology 364, 342-354 (2007).
20. Harcourt, B.H., Sanchez, A. & Offermann, M.K. Ebola virus inhibits induction of genes by double-stranded RNA in endothelial cells. Virology 252, 179-188 (1998).
21. Jahrling, P.B. et al. Evaluation of immune globulin and recombinant interferon-α2b for treatment of experimental Ebola virus infections. J. Infect. Dis. 179 (suppl. 1), S224-S234(1999).
22. Kash, J.C. et al. Global suppression of the host antiviral response by Ebola- and Marburgviruses: Increased antagonism of the type I interferon response is associated with enhanced virulence. J. Virol. 80, 3009-3020 (2006).
23. Mahanty, S. et al. Protection from lethal infection is determined by innate immune responses in a mouse model of Ebola virus infection. Virology 312, 415-424 (2003).
24. Harcourt, B. H., Sanchez, A. & Offermann, M.K. Ebola virus selectively inhibits responses to interferons, but not to interleukin-1β, in endothelial cells. J. Virol. 73, 3491-3496 (1999).
25. Bray, M. The role of the type I interferon response in the resistance of mice to filovirus infection. J. Gen. Virol. 82, 1365-1373 (2001).
26. Basler, C.F. et al. The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J. Virol. 77, 7945-7956 (2003).
27. Reid, S.P. et al. Ebola virus VP24 binds karyopherin α1 and blocks STAT1 nuclear accumulation. J. Virol. 80, 5156-5167 (2006).
28. Cardenas, W.B. et al. Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling. J. Virol. 80, 5168-5178 (2006).
29. Feng, Z., Cerveny, M., Yan, Z. & He, B. The VP35 protein of Ebola virus inhibits the antiviral affect mediated by double-stranded RNA-ddipendent protein kinase PKR. J. Virol. 81, 182-192 (2007).
30. Baize, S. et al. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-injected patients. Nat. Med. 5, 423-426 (1999).
31. Reed, D.S., Hensley, L.E., Geisbert, J.B., Jahrling, P.B. & Geisbert, T.W. Depletion of peripheral blood T lymphocytes and NK-cells during the course of Ebola hemorrhagic fever in cynomolgus macaques. Viral Immunol. 17, 390-400 (2004).
32. Geisbert, T.W. et al. Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses. Lab. Invest. 80 171-186 (2000).
33. Sanchez, A. et al. Analysis of human peripheral blood samples from fatal and,non-fatal cases of Ebola (Sudan) hemorrhagic fevel: Cellular responses, virus load, and nitric oxide levels. J. Virol. 78 10370-10377 (2004).
34. Geisbert, T.W. & Jahrling, P.B. Exotic emerging viral diseases: Progress and challenges. Nat. Med., 10, S110-S121 (2004).
35. Feldmann, H. et al. Effective post-exposure treatment of Ebola, infection. PloS Pathog. [online] 3, e2 (2007).
36. Sullivan, N.J., Sanchez, A., Rollin, P.E., Yang, Z.-Y. & Nabel, G.J. Development of a preventive vaccine for Ebola virus infection in primates. Nature 408, 605-609 (2000).
37. Sullivan, N.J. et al. Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates. Nature 424, 681-684 (2003).
38. Bukreyev, A. et al. Successful topical respiratory tract immunization of primates against Ebola virus. J. Virol. 81, 6379-6388 (2007).
39. Warfield, K.L. et al. Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection. J. Immunol. 175, 1184-1191 (2005).
40. Oswald, W.B. et al. Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys. PLoS Pathog. [online] 3, e9 (2007).
41. Mahanty, S. & Bray, M. Pathogenesis of filoviral haemorrhagic fevers. Lancet Infect. Dis. 4, 487-498 (2004).
42. Mohamadzadeh, M., Chen, L. & Schmaljohn, A.L. How Ebola and Marburg viruses battle the immune system. Nat. Rev. Immunol. 7, 556-567 (2007).
43. Dietrich, M., Schumacher, H.H., Peters, D. & Knobloch, J. Human pathology of Ebola (Maridi) virus infection in the Sudan. In Ebola Virus Haemorrhagic Fever (ed. Pattyn, S.R.) 37-42 (Elsevier, Amsterdam, 1978).
44. Murphy, F. An atlas of viral disease pathogenesis. In Viral Pathogenesis (eds. Nathanson, N. et al.) 433-463 (Lippincott Williams & Wilkins, Philadelphia, 1997).
45. Anonymous. Ebola haemorrhagic fever in Zaire, 1976. Bull. World Health Organ. 56, 271-293 (1978).
46. Jahrling, P.B. et al. Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses. Arch. Virol. Suppl. 11, 135-140 (1996).
47. Towner, J.S. et al. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J. Virol. 76, 4330-4341 (2004).
48. Fisher-Hoch, S.P. et al. Pathogenic potential of filoviruses: Role of geographic origin of primate host and virus strain. J. Infect. Dis. 166, 753-763 (1992).
49. Johnson, E., Jaax, N., White, J. & Jahrling, P. Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus. Int. J. Exp. Pathol. 76, 227-236 (1995).
50. Ryabchikova, E.I., Kolesnikova, L.V. & Luchko, S.V. An analysis of features of pathogenesis in two animal models of Ebola virus infection. J. Infect. Dis. 179 (suppl. 1), S199-S202 (1999).
51. Stolpen, A.H., Guinan, E.C., Fiers, W. & Pober, J.S. Recombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human vascular endothelial Cell monolayers. Am. J. Pathol. 123, 16-24 (1986).
52. Simmons, G., Wool-Lewis, R.J., Baribaud, F., Netter, R.C. & Bates, P. Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence. J. ViroJ. 76, 2518-2528 (2002).
53. Sullivan, N.J. et al. Ebola virus glycoprotein toxicity is mediated by a dynamindependent protein-trafficking pathway. J. Virol. 79, 547-553 (2005).
54. Ito, H. et al. Ebola virus glycoprotein: Proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies. J. Virol. 75, 1576-1580 (2001).
55. Dolnik, O. et al. Ectodomain shedding of the glycoprotein GP of Ebola virus. EMBO J. 23, 2175-2184 (2004).
56. Sanchez, A. et al. Biochemical analysis of the secreted and virion glycoproteins of Ebola virus. J. Virol. 72, 6442-6447 (1998).
57. Yang, Z. et al. Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins. Science 279, 1034-1037 (1998).
58. Chandran, K., Sullivan, N.J., Felbor, U., Whelan, S.P. & Cunningham, J.M. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308, 1643-1645 (2005).
59. Schornberg, K. et al. Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J. Virol. 80, 4174-4178 (2006).
60. Barrientos, L.G. & Rollin, P.E. Release of cellular proteases into the acidic extra-cellular milieu exacerbates Ebola virus-induced cell damage. Virology 358, 1-9 (2007).
61. Yang, Z.-Y. et al. Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat. Med. 6, 886-889 (2000).
62. Alazard-Dany, N. et al. Ebola virus glycoprotein GP is not cytotoxic when expressed constitutively at a moderate level. J. Gen. Virol. 87, 1247-1257 (2006).
63. Volchkov, V.E. et al. Recovery of infecticus Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity. Science 291, 1965-1969 (2001).
64. Ksiazek, T.G., West, C.P., Rollin, P.E., Jahrling, P.B. & Peters, C.J. ELISA for the detection of antibodies to Ebola viruses J. Infect. Dis. 179, S192-S198 (1999).
65. Baize, S. et al. Inflammatory responses in Ebola virus-infected patients. Clin. Exp. Immunol. 128, 163-168 (2002).
66. Ahmed, R., Oldstone, M.B.A. & Palese, P. Protective immunity and susceptibility to infectious diseases: Lessons from the 1918 influenza pandemic. Nat. Immunol. 8, 1188-1193 (2007).
67. Kobasa, D. et al. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 445 319-323 (2007).